US2015337335A1PendingUtilityA1
Rationally-Designed Single-Chain Meganucleases With Non-Palindromic Recognition Sequences
Est. expiryOct 31, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61P 31/12A61P 31/04A61P 33/02A61P 43/00A61P 31/00C12N 15/907C12N 9/16C12N 9/22C12Y 301/04C12N 15/8509C12Y 301/00C12N 2800/80C12N 15/902
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are rationally-designed, non-naturally-occurring meganucleases in which a pair of enzyme subunits having specificity for different recognition sequence half-sites are joined into a single polypeptide to form a functional heterodimer with a non-palindromic recognition sequence. The invention also relates to methods of producing such meganucleases, and methods of producing recombinant nucleic acids and organisms using such meganucleases.
Claims
exact text as granted — not AI-modified1 - 17 . (canceled)
18 . A method for producing a genetically-modified eukaryotic cell including an exogenous sequence of interest inserted in a chromosome of said eukaryotic cell, comprising:
transfecting a eukaryotic cell with one or more nucleic acids including (i) a first nucleic acid sequence encoding a meganuclease, and (ii) a second nucleic acid sequence including said sequence of interest; wherein said meganuclease produces a cleavage site in said chromosome and said sequence of interest is inserted into said chromosome at said cleavage site; and wherein said meganuclease is a recombinant single-chain meganuclease of claim 38 .
19 . A method as in claim 18 wherein:
said second nucleic acid further comprises sequences homologous to sequences flanking said cleavage site and said sequence of interest is inserted at said cleavage site by homologous recombination.
20 . A method as in claim 18 wherein:
said second nucleic acid lacks substantial homology to said cleavage site and said sequence of interest is inserted into said chromosome by non-homologous end joining.
21 . A method for producing a genetically-modified eukaryotic cell including an exogenous sequence of interest inserted in a chromosome of said eukaryotic cell, comprising:
introducing a meganuclease protein into a eukaryotic cell; and transfecting said eukaryotic cell with a nucleic acid including said sequence of interest; wherein said meganuclease produces a cleavage site in said chromosome and said sequence of interest is inserted into said chromosome at said cleavage site; and wherein said meganuclease is a recombinant single-chain meganuclease of claim 38 .
22 . A method as in claim 21 wherein:
said nucleic acid further comprises sequences homologous to sequences flanking said cleavage site and said sequence of interest is inserted at said cleavage site by homologous recombination.
23 . A method as in claim 21 wherein:
said nucleic acid lacks substantial homology to said cleavage site and said sequence of interest is inserted into said chromosome by non-homologous end joining.
24 . A method for producing a genetically-modified eukaryotic cell by disrupting a target sequence in a chromosome of said eukaryotic cell, comprising:
transfecting a eukaryotic cell with a nucleic acid encoding a meganuclease; wherein said meganuclease produces a cleavage site in said chromosome and said target sequence is disrupted by non-homologous end joining at said cleavage site; and wherein said meganuclease is a recombinant single-chain meganuclease of claim 38 .
25 . A method of producing a genetically-modified non-human organism comprising:
producing a genetically-modified non-human eukaryotic cell according to the method of claim 24 ; and growing said genetically-modified non-human eukaryotic cell to produce said genetically-modified non-human organism.
26 . A method as in claim 25 wherein:
said non-human eukaryotic cell is selected from the group consisting of a gamete, a zygote, a blastocyst cell, an embryonic stem cell, and a protoplast cell.
27 - 37 . (canceled)
38 . A recombinant single-chain meganuclease comprising:
(a) a first subunit comprising a polypeptide having at least 85% sequence identity to residues 9-151 of SEQ ID NO: 1; (b) a second subunit comprising a polypeptide having at least 85% sequence identity to residues 9-151 of SEQ ID NO: 1; and (c) a polypeptide linker comprising 28-45 amino acids, said polypeptide linker being covalently bound to said first and said second subunit; said first subunit being covalently bound to said polypeptide linker at a residue corresponding to a position selected from the group of positions 153-163 of SEQ ID NO: 1; said second subunit being covalently bound to said polypeptide linker at a residue corresponding to a position selected from the group of positions 1-9 of SEQ ID NO: 1; wherein said first and second subunits are capable of functioning together to recognize and cleave a non-palindromic DNA sequence.
39 . The recombinant single-chain meganuclease of claim 38 , wherein said polypeptide linker comprises at least 50% of polar uncharged amino acids.
40 . The recombinant single-chain meganuclease of claim 41 , wherein said polypeptide linker comprises from the N-terminus to the C-terminus a first loop, a first α-helix, a first turn, a second α-helix, and a second loop.
41 . The recombinant single-chain meganuclease of claim 38 , wherein said polypeptide linker comprises:
(a) an SX 1 PGSX 2 GGX 3 (SEQ ID NO:111) motif, wherein X 1 is L or blank, X 2 is V or L, and X 3 is L, I, or V; (b) an SPSQASSAASS (SEQ ID NO:112) motif, an SPSQASSAASSASSS (SEQ ID NO:113) motif, or an SPSQASSAASSASSAASS (SEQ ID NO:114) motif; (c) a PGSGX 4 (SEQ ID NO:115) motif, wherein X 4 is I, T, P, V, L, S or A; and (d) an SEAX 5 RAGX 6 A (SEQ ID NO:116) motif or an SEAX 5 RASSAGX 6 A (SEQ ID NO:117) motif, wherein X 5 is L, T, S, or I, and wherein X 6 is blank or G.
42 . The recombinant single-chain meganuclease of claim 40 , wherein:
(a) said first loop comprises said SX 1 PGSX 2 GGX 3 (SEQ ID NO:111) motif; (b) said first α-helix comprises said SPSQASSAASS (SEQ ID NO:112) motif, said SPSQASSAASSASSS (SEQ ID NO:113) motif, or said SPSQASSAASSASSAASS (SEQ ID NO:114) motif; (c) said first turn comprises said PGSGX 4 (SEQ ID NO:115) motif; and (d) said SEAX 5 RAGX 6 A (SEQ ID NO:116) motif or said SEAX 5 RASSAGX 6 A (SEQ ID NO:117) motif spans the 3′ end of said second α-helix and the 5′ end of said second loop.
43 . The recombinant single-chain meganuclease of claim 40 , wherein said polypeptide linker comprises a C-capping motif spanning the 3′ end of said second α-helix and the 5′ end of said second loop, wherein said C-capping motif comprises an AX 7 RAGX 8 A (SEQ ID NO:118) motif, wherein X 7 is L, T, S, or I, and wherein X 8 is blank or G.Join the waitlist — get patent alerts
Track US2015337335A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.